These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28238190)

  • 1. Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial.
    Bo S; Ponzo V; Evangelista A; Ciccone G; Goitre I; Saba F; Procopio M; Cassader M; Gambino R
    Acta Diabetol; 2017 May; 54(5):499-507. PubMed ID: 28238190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial.
    Bo S; Ponzo V; Ciccone G; Evangelista A; Saba F; Goitre I; Procopio M; Pagano GF; Cassader M; Gambino R
    Pharmacol Res; 2016 Sep; 111():896-905. PubMed ID: 27520400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation.
    Bo S; Togliatto G; Gambino R; Ponzo V; Lombardo G; Rosato R; Cassader M; Brizzi MF
    Acta Diabetol; 2018 Apr; 55(4):331-340. PubMed ID: 29330620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.
    Seyyedebrahimi S; Khodabandehloo H; Nasli Esfahani E; Meshkani R
    Acta Diabetol; 2018 Apr; 55(4):341-353. PubMed ID: 29357033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial.
    Bo S; Gambino R; Ponzo V; Cioffi I; Goitre I; Evangelista A; Ciccone G; Cassader M; Procopio M
    Nutr Diabetes; 2018 Sep; 8(1):51. PubMed ID: 30237505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Patients With Type 2 Diabetes Mellitus.
    Imamura H; Yamaguchi T; Nagayama D; Saiki A; Shirai K; Tatsuno I
    Int Heart J; 2017 Aug; 58(4):577-583. PubMed ID: 28701674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum pentraxin 3 concentrations with diabetic nephropathy.
    Wang R; Zhang J; Hu W
    J Investig Med; 2016 Aug; 64(6):1124-7. PubMed ID: 27233528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial.
    Bo S; Ciccone G; Castiglione A; Gambino R; De Michieli F; Villois P; Durazzo M; Cavallo-Perin P; Cassader M
    Curr Med Chem; 2013; 20(10):1323-31. PubMed ID: 23298135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus.
    Wong RH; Nealon RS; Scholey A; Howe PR
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):393-9. PubMed ID: 27105868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative methylprednisolone increases plasma Pentraxin 3 early after total knee arthroplasty: a randomized, double-blind, placebo-controlled trial.
    Lindberg-Larsen V; Kehlet H; Pilely K; Bagger J; Rovsing ML; Garred P
    Clin Exp Immunol; 2018 Mar; 191(3):356-362. PubMed ID: 29119559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and Vitreous Pentraxin 3 Concentrations in Patients with Diabetic Retinopathy.
    Zhou W; Hu W
    Genet Test Mol Biomarkers; 2016 Mar; 20(3):149-53. PubMed ID: 26836044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Resveratrol Consumption Improves Neurovascular Coupling Capacity in Adults with Type 2 Diabetes Mellitus.
    Wong RH; Raederstorff D; Howe PR
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial.
    Panahi Y; Khalili N; Sahebi E; Namazi S; Simental-Mendía LE; Majeed M; Sahebkar A
    Drug Res (Stuttg); 2018 Jul; 68(7):403-409. PubMed ID: 29458218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
    Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
    Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease.
    Hoseini A; Namazi G; Farrokhian A; Reiner Ž; Aghadavod E; Bahmani F; Asemi Z
    Food Funct; 2019 Sep; 10(9):6042-6051. PubMed ID: 31486447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial.
    Panahi Y; Khalili N; Sahebi E; Namazi S; Karimian MS; Majeed M; Sahebkar A
    Inflammopharmacology; 2017 Feb; 25(1):25-31. PubMed ID: 27928704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the association of plasma pentraxin 3 levels with type 2 diabetes and diabetic nephropathy in a Malay population.
    Abu Seman N; Witasp A; Wan Mohamud WN; Anderstam B; Brismar K; Stenvinkel P; Gu HF
    J Diabetes Res; 2013; 2013():298019. PubMed ID: 24350299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Resveratrol Supplementation on Cardio-Metabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized, Double-Blind Controlled Trial.
    Abdollahi S; Salehi-Abargouei A; Toupchian O; Sheikhha MH; Fallahzadeh H; Rahmanian M; Tabatabaie M; Mozaffari-Khosravi H
    Phytother Res; 2019 Dec; 33(12):3153-3162. PubMed ID: 31475415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study.
    Samsamikor M; Daryani NE; Asl PR; Hekmatdoost A
    Arch Med Res; 2016 May; 47(4):304-9. PubMed ID: 27664491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.